Stock listing

LS Exchange:A40P4H ExpreS2ion Biotech Holding AB Aktie

German listing (LS Exchange) of ExpreS2ion Biotech Holding AB · home listing Stockholm:EXPRS2

Follow ExpreS2ion Biotech Holding AB into a list and get an email when it puts out news.

Home listing price · OMXSTO:EXPRS2

0.992 SEK +0.058 (+6.2%)

Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, OMXSTO:EXPRS2

Past year -83.7% · daily closes, Nov 3, 2025 – Nov 2, 2026, adjusted for splits
Day range
0.900 – 1.000 SEKNov 2, 2026
Volume
64,529 sharesNov 2, 2026
Market cap
9.80M SEKAt the close on Nov 2, 2026 · price × 9.88M shares outstanding
52-week range
0.880 – 6.980 SEKLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
Traded on an average day
159,150 SEKMedian day 72,869 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
ExpreS2ion Biotech Holding AB logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Stockholm:EXPRS2 · Home0.992 SEK+0.058 (+6.2%)64,5290.9361.0000.9000.934Close on Nov 2, 2026
Frankfurt:5JD0€0.055 EUR-0.004 (-6.4%)—€0.055€0.055€0.055€0.059Close on Oct 30, 2026

Daily closes

Last 3 months, Aug 3, 2026 – Nov 2, 2026 · OMXSTO:EXPRS2 · SEK, adjusted for splits

DayCloseChange%OpenHighLowVolume
0.992+0.058+6.2%0.9361.0000.90064,529
0.9340.0000.0%0.9340.9500.93436,006
0.934-0.096-9.3%0.9981.0100.934117,309
1.030-0.010-1.0%1.0401.0400.96020,299
1.040+0.050+5.1%1.0001.0450.92877,809
0.990-0.060-5.7%1.0501.0500.900307,308
1.050-0.030-2.8%1.0151.1050.980264,441
1.080+0.020+1.9%0.9781.0800.96846,533
1.0600.0000.0%1.0601.0700.96816,809
1.060+0.040+3.9%1.0001.0601.00028,020
1.020-0.010-1.0%0.9661.0450.95626,676
1.0300.0000.0%0.9801.0600.96630,117
1.0300.0000.0%0.9021.0300.880292,957
1.030-0.060-5.5%1.0901.0900.914146,931
1.090+0.010+0.9%1.0951.0951.03074,702
1.080-0.010-0.9%1.0901.1401.02078,301
1.090+0.035+3.3%1.0401.1501.04065,645
1.055-0.005-0.5%1.0601.0600.98253,473
1.060-0.065-5.8%1.1251.1251.04029,230
1.125+0.005+0.4%1.1301.1301.09085,393
1.120+0.025+2.3%1.1201.1251.08053,873
1.095-0.070-6.0%1.1051.1501.080162,264
1.165-0.025-2.1%1.1951.1951.13537,655
1.190+0.025+2.1%1.1651.2001.090140,322
1.165+0.050+4.5%1.0801.1651.07050,192
1.115-0.015-1.3%1.1301.1351.08537,111
1.130+0.005+0.4%1.1151.1501.08041,912
1.125-0.055-4.7%1.1701.1701.04073,211
1.180-0.025-2.1%1.2051.2351.18040,671
1.205-0.025-2.0%1.2351.2351.19572,526
1.230-0.090-6.8%1.3201.3201.21070,631
1.320+0.020+1.5%1.3001.3201.24039,187
1.300-0.030-2.3%1.2251.3251.22528,716
1.330+0.005+0.4%1.3451.3901.27563,425
1.325+0.075+6.0%1.2951.4001.290201,136
1.2500.0000.0%1.2501.3001.20533,844
1.250-0.005-0.4%1.2151.3551.21522,555
1.255-0.030-2.3%1.2851.2851.20574,080
1.285-0.065-4.8%1.3051.3251.28515,547
1.3500.0000.0%1.2901.3701.29054,480
1.350+0.005+0.4%1.3701.3701.28535,265
1.345-0.050-3.6%1.3201.3751.29047,307
1.395+0.065+4.9%1.3301.4001.250158,636
1.330-0.085-6.0%1.3251.4101.27033,613
1.415+0.110+8.4%1.3001.4151.25576,290
1.305+0.005+0.4%1.3001.3101.23587,583
1.300+0.055+4.4%1.2451.3001.21034,418
1.245-0.035-2.7%1.2751.2901.150338,627
1.280-0.100-7.2%1.3951.3951.100546,063
1.380+0.040+3.0%1.3351.4001.300174,168
1.340-0.060-4.3%1.4001.4001.30549,385
1.400+0.015+1.1%1.4451.4451.325362,557
1.385-0.010-0.7%1.4251.4901.310223,360
1.395+0.095+7.3%1.2801.4851.220494,293
1.300-0.050-3.7%1.3501.3801.280152,332
1.350-0.085-5.9%1.4351.4351.305263,037
1.435-0.010-0.7%1.4451.4651.360153,649
1.445-0.015-1.0%1.4501.4651.355109,137
1.460-0.065-4.3%1.6601.7301.340955,706
1.525+0.065+4.5%1.4751.6001.450149,147
1.460+0.035+2.5%1.4601.5401.460129,070
1.425+0.015+1.1%1.4351.4901.405140,624
1.410+0.075+5.6%1.3351.4401.335104,683
1.335-0.055-4.0%1.3901.3901.330135,123
1.390-0.025-1.8%1.3801.4151.35071,819
1.415-0.015-1.0%1.4301.4301.38025,946
Ticker
LS Exchange:A40P4H
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
LS Exchange
Currency
EUR

What changed lately

Calls

Replays

  • Expres2ion Biotech Holding (Stockholm:EXPRS2) Q2 2026 Earnings Call

    Thu, Aug 20, 2026 · 4:00 AM ET

    Watch Transcript

  • Expres2ion Biotech Holding (Stockholm:EXPRS2) Q1 2026 Earnings Call

    Thu, May 28, 2026 · 4:00 AM ET

    Watch Transcript

  • Expres2ion Biotech Holding (Stockholm:EXPRS2) Q4 2025 Earnings Call

    Thu, Feb 19, 2026 · 3:00 AM ET

    Watch Transcript

Latest news

ExpreS2ion Biotech Obtains Commitment for Warrant Program TO 13 and enters into SEK 50 Million Put Option Agreement with lead investor Alumni Capital

Sep 14, 2026

Closed 1.33 (+6.0%) on Sep 15, 2026

ExpreS2ion Announces Financial Results for the Second Quarter and First Half of 2026

Aug 20, 2026

Closed 1.39 (-0.7%) on Aug 20, 2026

ExpreS2ion annual report for 2025 published

Jun 4, 2026

Closed 1.63 (+0.9%) on Jun 4, 2026

ExpreS2ion Announces Financial Results for the First Quarter of 2026

May 28, 2026

Closed 1.66 (-0.3%) on May 28, 2026

ExpreS2ion resolves on a set-off issue to one guarantor in connection with completed rights issue

May 11, 2026

Closed 1.98 (+2.9%) on May 12, 2026

ExpreS2ion Biotech: Rights issue outcome – SEK31.8m raised

May 5, 2026

Closed 1.97 (+0.3%) on May 5, 2026

ExpreS2ion announces final outcome of its rights issue of units

May 4, 2026

Closed 1.97 (+0.3%) on May 5, 2026

ExpreS2ion Biotech advances breast cancer project with rights issue of SEK 53 million

Apr 20, 2026

Closed 2.37 (+3.9%) on Apr 20, 2026

ExpreS2ion featured in BioStock investor presentation as subscription period opens in SEK 53 million rights issue

Apr 16, 2026

Closed 2.28 (-2.6%) on Apr 17, 2026

ExpreS2ion publishes prospectus in connection with SEK 53 million rights issue to complete Phase I and support partnering activities

Apr 14, 2026

Closed 3.55 (-27.6%) on Apr 14, 2026

All ExpreS2ion Biotech Holding AB news

Financings

  • New shares on exercise of TO 13 warrants and directed issue to guarantor

    Sep 14, 2026 · US$1.98M

    Announced: SEK 19.3M–SEK 32.4M · SEK 1.6 a share · Vator Securities +2

    Dealers: Vator Securities, SCHMIDT Capital Advisors, APREA Partners

    Buyers: Vator Securities (guarantee undertaking totalling SEK 19.3 million); Alumni Capital; Tellus Equity AB; Leif Helth Jensen; John Haurum; Thomas Larsson

    Use of proceeds: Complete the ES2B-C001 Phase I study, strengthen licensing negotiations, platform and CMC development, and business development

    Announced Sep 14, 2026

  • New shares under put option agreement

    Sep 14, 2026 · US$5.12M

    Announced: up to SEK 50M

    Buyers: Alumni Capital Limited (commitment of up to SEK 50,000,000 in equity financing over 24 months)

    Announced Sep 14, 2026

Read by 6ix AI from the company's releases

Decks

ExpreS2ion Biotech Holding AB on 6ix

Sector
Health care
Industry
Biotechnology
News releases
12 in the last 12 months · 12 in all · newest Sep 14, 2026 · oldest 2026
Calls
10 calls with a replay · 10 with a transcript · latest Aug 20, 2026
Decks
52 decks · latest Oct 7, 2026

Where ExpreS2ion Biotech Holding AB is listed

ListingExchangeCountryCurrency
Stockholm:EXPRS2 · Home listingStockholmSwedenSEK
LS Exchange:A40P4H · This pageLS ExchangeGermanyEUR
Lang & Schwarz:A40P4HLang & SchwarzGermanyEUR
gettex:5JD0gettexGermanyEUR
Stuttgart:5JD0StuttgartGermanyEUR
Frankfurt:5JD0FrankfurtGermanyEUR
Munich:5JD0MunichGermanyEUR

Log in to ask 6ix AI your own questions about ExpreS2ion Biotech Holding AB.